Soleus Capital Management as of Sept. 30, 2025
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 88 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 9.1 | $180M | 1.0M | 176.53 | |
| Tg Therapeutics (TGTX) | 7.0 | $139M | 3.8M | 36.12 | |
| Novocure Ord Shs (NVCR) | 6.3 | $125M | 9.6M | 12.92 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 5.8 | $115M | 1.2M | 100.20 | |
| Anthem (ELV) | 4.2 | $84M | 260k | 323.12 | |
| Beta Bionics (BBNX) | 3.9 | $77M | 3.9M | 19.87 | |
| United Therapeutics Corporation (UTHR) | 3.2 | $63M | 150k | 419.21 | |
| Terns Pharmaceuticals (TERN) | 3.1 | $61M | 8.1M | 7.51 | |
| Celcuity (CELC) | 2.9 | $58M | 1.2M | 49.40 | |
| Inspire Med Sys (INSP) | 2.7 | $54M | 728k | 74.20 | |
| Twist Bioscience Corp (TWST) | 2.6 | $53M | 1.9M | 28.14 | |
| Argenx Se Sponsored Adr (ARGX) | 2.6 | $51M | 69k | 737.56 | |
| Organogenesis Hldgs (ORGO) | 2.6 | $51M | 12M | 4.22 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $48M | 890k | 54.16 | |
| Cidara Therapeutics Com New (CDTX) | 2.4 | $47M | 494k | 95.76 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.3 | $46M | 859k | 53.00 | |
| Amicus Therapeutics (FOLD) | 1.9 | $37M | 4.7M | 7.88 | |
| Indivior Ord (INDV) | 1.8 | $35M | 1.5M | 24.11 | |
| Madrigal Pharmaceuticals (MDGL) | 1.6 | $31M | 68k | 458.66 | |
| Biosante Pharmaceuticals (ANIP) | 1.6 | $31M | 340k | 91.60 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $31M | 2.0M | 15.38 | |
| Axogen (AXGN) | 1.6 | $31M | 1.7M | 17.84 | |
| Neuropace (NPCE) | 1.5 | $31M | 3.0M | 10.31 | |
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 1.3 | $25M | 2.5M | 9.96 | |
| Geron Corporation (GERN) | 1.2 | $24M | 17M | 1.37 | |
| Nurix Therapeutics (NRIX) | 1.1 | $22M | 2.4M | 9.24 | |
| Integra Lifesciences Hldgs C Com New (IART) | 1.0 | $21M | 1.4M | 14.33 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $19M | 138k | 140.38 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $19M | 626k | 30.62 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.8 | $17M | 7.3M | 2.29 | |
| Pharvaris N V (PHVS) | 0.8 | $16M | 647k | 24.95 | |
| Vericel (VCEL) | 0.8 | $16M | 498k | 31.47 | |
| C4 Therapeutics Com Stk (CCCC) | 0.8 | $16M | 7.1M | 2.22 | |
| Belite Bio Sponsored Ads (BLTE) | 0.8 | $16M | 210k | 74.00 | |
| Veracyte (VCYT) | 0.7 | $15M | 422k | 34.33 | |
| Rapt Therapeutics Com New (RAPT) | 0.7 | $14M | 538k | 25.79 | |
| Urogen Pharma (URGN) | 0.7 | $14M | 679k | 19.95 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.7 | $13M | 500k | 26.87 | |
| Sionna Therapeutics (SION) | 0.6 | $12M | 414k | 29.41 | |
| Cg Oncology (CGON) | 0.6 | $12M | 290k | 40.28 | |
| Uniqure Nv SHS (QURE) | 0.6 | $12M | 200k | 58.37 | |
| Quidel Corp (QDEL) | 0.6 | $11M | 375k | 29.45 | |
| Mirum Pharmaceuticals (MIRM) | 0.5 | $11M | 149k | 73.31 | |
| Adma Biologics (ADMA) | 0.5 | $11M | 738k | 14.66 | |
| Inhibikase Therapeutics Com New (IKT) | 0.5 | $10M | 6.3M | 1.62 | |
| Globus Med Cl A (GMED) | 0.5 | $10M | 176k | 57.27 | |
| GSK Sponsored Adr (GSK) | 0.5 | $9.5M | 220k | 43.16 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $9.3M | 330k | 28.33 | |
| Evolus (EOLS) | 0.4 | $8.9M | 1.5M | 6.14 | |
| Verastem Com New (VSTM) | 0.4 | $8.3M | 936k | 8.83 | |
| Arcellx Common Stock (ACLX) | 0.4 | $8.2M | 100k | 82.10 | |
| Nuvalent Inc-a (NUVL) | 0.4 | $7.6M | 88k | 86.48 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $7.0M | 15k | 456.00 | |
| Jade Biosciences Com New (JBIO) | 0.3 | $6.9M | 797k | 8.63 | |
| Lb Pharmaceuticals Com Shs | 0.3 | $6.3M | 400k | 15.79 | |
| Olema Pharmaceuticals (OLMA) | 0.3 | $6.1M | 620k | 9.79 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.3 | $5.8M | 150k | 38.83 | |
| Establishment Labs Holdings Ord (ESTA) | 0.3 | $5.7M | 140k | 40.99 | |
| Mbx Biosciences (MBX) | 0.2 | $4.8M | 275k | 17.50 | |
| Erasca (ERAS) | 0.2 | $4.7M | 2.2M | 2.18 | |
| Eton Pharmaceuticals (ETON) | 0.2 | $4.3M | 200k | 21.73 | |
| Ceribell (CBLL) | 0.2 | $4.1M | 360k | 11.49 | |
| Harrow Health (HROW) | 0.2 | $4.1M | 86k | 48.18 | |
| Fractyl Health (GUTS) | 0.2 | $4.0M | 2.5M | 1.59 | |
| Jasper Therapeutics Com New (JSPR) | 0.2 | $3.6M | 1.5M | 2.38 | |
| Inspiremd (NSPR) | 0.2 | $3.5M | 1.5M | 2.41 | |
| Akero Therapeutics (AKRO) | 0.2 | $3.4M | 71k | 47.48 | |
| Ideaya Biosciences (IDYA) | 0.1 | $2.7M | 100k | 27.21 | |
| Tango Therapeutics (TNGX) | 0.1 | $2.5M | 300k | 8.40 | |
| Crescent Biopharma (CBIO) | 0.1 | $2.4M | 200k | 11.89 | |
| Rapport Therapeutics (RAPP) | 0.1 | $2.4M | 80k | 29.70 | |
| Orthopediatrics Corp. (KIDS) | 0.1 | $2.4M | 128k | 18.53 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $2.1M | 977k | 2.17 | |
| Calcimedica Com New (CALC) | 0.1 | $2.1M | 684k | 3.08 | |
| Vistagen Therapeutics Ord (VTGN) | 0.1 | $2.0M | 550k | 3.55 | |
| Mannkind Corp Com New (MNKD) | 0.1 | $1.6M | 300k | 5.37 | |
| Immunic (IMUX) | 0.1 | $1.4M | 1.6M | 0.88 | |
| Adverum Biotechnologies Com New (ADVM) | 0.1 | $1.3M | 287k | 4.53 | |
| Liquidia Corporation Com New (LQDA) | 0.1 | $1.1M | 50k | 22.74 | |
| Essa Pharma Com New (EPIX) | 0.0 | $833k | 4.4M | 0.19 | |
| Myomo Com New (MYO) | 0.0 | $628k | 704k | 0.89 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.0 | $617k | 300k | 2.06 | |
| Tectonic Therapeutic (TECX) | 0.0 | $392k | 25k | 15.69 | |
| Insmed Com Par $.01 (INSM) | 0.0 | $367k | 2.6k | 144.01 | |
| Septerna (SEPN) | 0.0 | $344k | 18k | 18.81 | |
| Kodiak Sciences (KOD) | 0.0 | $322k | 20k | 16.37 | |
| Trevi Therapeutics (TRVI) | 0.0 | $229k | 25k | 9.15 | |
| Delcath Sys Com New (DCTH) | 0.0 | $108k | 10k | 10.75 |
